Clinical Trial Update: Effect of Rosuvastatin in Intracerebral Hemorrhage [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating rosuvastatin for intracerebral hemorrhage and stroke has completed its Phase 2 status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage
• Stroke

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Universidad Autonoma de San Luis Potosí | Conditions: Intracerebral Hemorrhage, Stroke | Phase 2 | Status: COMPLETED